CIP2A is a prime synthetic-lethal target for BRCA-mutated cancers
Salomé Adam, Silvia Emma Rossi, Nathalie Moatti, Mara De Marco Zompit, Timothy F. Ng, Alejandro Álvarez-Quilón, Jessica Desjardins, Vivek Bhaskaran, Giovanni Martino, Dheva Setiaputra, Sylvie M. Noordermeer, Toshiro K. Ohsumi, Nicole Hustedt, Rachel K. Szilard, Natasha Chaudhary, Meagan Munro, Artur Veloso, Henrique Melo, Shou Yun Yin, Robert Papp, Jordan T.F. Young, Michael Zinda, Manuel Stucki, Daniel Durocher
bioRxiv 2021.02.08.430060; doi: https://doi.org/10.1101/2021.02.08.430060